buyWeak
Anthony G. Quinn bought $203k of GBIO
director at Generation Bio Co.. 210,791 shares at an average of $0.96, traded Jan 10, 2025, filed Jan 14, 2025.
Conviction score
37Value
$203k
210,791 shares
Holdings after
299,286
+238% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +12Trade size$203k at market
- +10Relative to holdingsHoldings up 238%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-001417, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 10, 2025 | POpen-market purchase Common Stock | +125,791 | $0.96 | $121k | 214,286 | Jan 14, 2025 |
| Jan 13, 2025 | POpen-market purchase Common Stock | +85,000 | $0.97 | $82k | 299,286 | Jan 14, 2025 |
Related signals
Other insiders at Generation Bio Co. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Generation Bio Co. | Antoinette Paone CHIEF OPERATING OFFICER | $18k 6,719 shares | -33% | |
| 18Weak | Generation Bio Co. | Antoinette Paone CHIEF OPERATING OFFICER | $3,961 2,445 shares | -30% | |
| 3Weak | Generation Bio Co. | Phillip Samayoa CHIEF STRATEGY OFFICER | $3,961 2,445 shares | -2% | |
| 45Moderate | Generation Bio Co. | Dannielle Appelhans director | $14k 8,000 shares | +67% | |
| 38Weak | Generation Bio Co. | Dannielle Appelhans director | $18k 12,000 shares | - | |
| 51Moderate | Generation Bio Co. | Donald William Nicholson director | $144k 100,000 shares | +88% | |
| 48Moderate | Generation Bio Co. | Anthony G. Quinn director | $125k 88,495 shares | - | |
| 58Moderate | Generation Bio Co. | Charles A Rowland Jr director | $478k 342,960 shares | +179% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.